When is immunotherapy recommended for bowel cancer?

Bowel cancers are not all biologically alike. Testing tumour tissue can identify repair or DNA features that make an immune-based treatment more relevant. The team also considers whether the cancer is in the colon or rectum, where it has spread, previous operations or medicines, bowel symptoms, and your general health. Immunotherapy can cause immune inflammation even though its target is cancer cells.

Ask whether your tumour has had the relevant laboratory tests and what the result means for treatment choices. Discuss whether immunotherapy is intended to shrink disease, control it, or follow another treatment. Tell the team about autoimmune illness, bowel or lung problems, organ transplant, and medicines such as steroids. Keep a record of bowel changes, fever, skin changes, and breathing symptoms.

Report persistent diarrhoea, severe abdominal pain, blood in the stool, vomiting, a new rash, cough, breathlessness, yellow skin, or unusual weakness promptly. Seek urgent help for severe pain with vomiting or a swollen abdomen, major bleeding, fainting, confusion, or serious breathing difficulty.

Which tumour feature supports immunotherapy? Is surgery or another medicine also needed? How will bowel blockage, infection, and immune side effects be recognised?